. Author manuscript; available in PMC: 2016 Jun 10.

Published in final edited form as: J Psychopharmacol. 2015 Mar 18;29(8):892–897. doi: 10.1177/0269881115576688

Table 1. Demographic and Clinical Data.

N		36
Age in years (S.D.)		40.6 (11.1)
Male gender, n,(%)		28 (78)
Ethnicity, n(%)	Black	19 (53)
	White British	11 (31)
	Other	6 (17)
Diagnosis, n(%)	Schizophrenia	27 (75)
	Schizoaffective	7(19)
	Other	2(6)
Antipsychotic, n(%)	Olanzapine	19 (53)
	Amisulpride	6 (17)
	Aripiprazole	5 (14)
	Quetiapine	2(6)
	Risperidone	3 (8)
	Haloperidol	1 (3)
Average dose, CPZ equiv¹² mg/day (S.D.)		586 (251)
Length of treatment with current antipsychotic in months (SD)		57 (49)
PANSS, mean (S.D.)	Positive	21.7 (9.9)
	Negative	16.7 (6.9)
	General	39.1 (13.8)
	Total	77.1 (25.2)